Suraksha Diagnostic Limited (BOM:544293)
India · Delayed Price · Currency is INR 326.15
+21.25 (6.97%)
At close: Aug 21, 2026
Suraksha Diagnostic Revenue
Suraksha Diagnostic had revenue of 876.45M INR in the quarter ending June 30, 2026, with 20.75% growth. This brings the company's revenue in the last twelve months to 3.25B, up 23.31% year-over-year. In the fiscal year ending March 31, 2026, Suraksha Diagnostic had annual revenue of 3.10B with 23.13% growth.
Revenue (ttm)
3.25B
Revenue Growth
+23.31%
P/S Ratio
5.21
Revenue / Employee
2.50M
Employees
1,300
Market Cap
16.97B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 3.10B | 583.21M | 23.13% |
| Mar 31, 2025 | 2.52B | 333.84M | 15.26% |
| Mar 31, 2024 | 2.19B | 285.75M | 15.03% |
| Mar 31, 2023 | 1.90B | -330.59M | -14.81% |
| Mar 31, 2022 | 2.23B | 831.87M | 59.42% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Thyrocare Technologies | 8.76B |
| One Global Service Provider | 5.13B |
| Chandan Healthcare | 2.94B |
| Star Imaging and Path Lab | 885.27M |
| Modern Diagnostic & Research Centre | 841.37M |
| Pramodini Medicare | 622.88M |
| Invicta Diagnostic | 330.42M |
| Aspira Pathlab & Diagnostics | 259.03M |